BMA to Evaluate Cass Review on Pediatric Gender Transition Treatment, Despite High Court Endorsement

Jul 31, 2024, 03:44 PM

The British Medical Association (BMA) has announced it will undertake an evaluation of the Cass Review, which found that pediatric gender transition treatment is based on 'remarkably weak evidence.' This decision follows a recent vote by the BMA's Council in favor of a motion to publicly critique the review. The announcement comes shortly after the High Court described the Cass Review as 'the best and most up to date scientific evidence available.' Additionally, the High Court ruled that ministers have the right under the 1968 Medicines Act to make decisions based on the Cass Review. The BMA's move has sparked significant debate within the medical community.